Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Twist Bioscience Corporation - Common Stock
(NQ:
TWST
)
32.01
+0.31 (+0.98%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Twist Bioscience Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
May 02, 2024
From
Twist Bioscience Corporation
Via
Business Wire
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
↗
April 30, 2024
Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future.
Via
InvestorPlace
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
April 18, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Analyst Scoreboard: 5 Ratings For Twist Bioscience
↗
April 10, 2024
Via
Benzinga
4 Analysts Have This To Say About Twist Bioscience
↗
February 05, 2024
Via
Benzinga
Twist Bioscience Earnings Preview
↗
February 01, 2024
Via
Benzinga
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
↗
March 28, 2024
Via
Benzinga
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
March 28, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
March 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
↗
February 26, 2024
On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ:
Via
Benzinga
Twist Bioscience to Present at Upcoming Investor Conferences
February 22, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Is The Stock Market Ready To Plunge? The Warning Signs Are Here...
↗
February 21, 2024
Find out how to spot the exhaustion of demand and the bearish analogue you could refer to to anticipate the down move.
Via
Talk Markets
7 Stocks Cathie Wood Is Still Loading Up On in Q1
↗
February 13, 2024
You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future.
Via
InvestorPlace
7 Sexy Stocks That Will Continue to Outperform in 2024
↗
February 11, 2024
These outperforming stocks are prime candidates for increasing in value sharply this year and beyond. Discover the top picks.
Via
InvestorPlace
Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss
↗
February 08, 2024
Via
Benzinga
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M
↗
February 07, 2024
Via
Benzinga
Topics
Artificial Intelligence
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
February 07, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
February 06, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
February 06, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
February 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Why Is DNA Synthesis Company Twist Bioscience Stock Trading Higher Today?
↗
February 02, 2024
Twist Bioscience reported Q1 2024 earnings, beating revenue guidance and increasing FY24 guidance. Shares are up 7.16%.
Via
Benzinga
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
February 02, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Earnings Scheduled For February 2, 2024
↗
February 02, 2024
Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion.
Via
Benzinga
Twist Bioscience Corp Daily Investment Opportunity
↗
January 25, 2024
Twist Bioscience is a public biotechnology company founded in 2013 and it’s based in South San Francisco. It manufactures synthetic DNA and DNA products for customers in a wide range of industries.
Via
Talk Markets
Twist Bioscience Expands Express Genes Rapid Synthesis Service
January 24, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
↗
January 17, 2024
Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing...
Via
Benzinga
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
January 17, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
January 16, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Biotech Playbook: Small Caps Show Momentum Peaking During
↗
January 15, 2024
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.
Via
Talk Markets
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
January 08, 2024
From
Twist Bioscience Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
